Seres Health Inc Headquarters
Looking for information about Seres Health Inc Headquarters? The links below have collected all the necessary data.
Seres Therapeutics
- https://www.serestherapeutics.com/
- Inside Seres; Contact Us; Close latest news. Our latest news . Recurrent C. diff study now enrolling An open-label study of SER-109. LEARN MORE . Target enrollment achieved in Phase 2b SER-287 study Topline clinical data expected in mid-2021. READ MORE
Seres Therapeutics Company Profile - Office Locations ...
- https://craft.co/seres-health
- Jul 22, 2021 · Seres Therapeutics is a microbiome therapeutics platform company which engages in developing biological drugs designed to restore health by repairing the function of a dysbiotic microbiome. Its lead product candidate is SER-109, a bacterial spore ecology to treat multiply recurrent Clostridium difficile infection.Employees: 108
About Us – Seres Therapeutics
- https://www.serestherapeutics.com/about-us/
- Seres’ partnership with Nestlé Health Science, announced Jan. 11, 2016, pertains to C. difficile and IBD programs for markets outside of North America. Seres is partnering with the University of Texas MD Anderson Cancer Center and the Parker Institute for Cancer Immunotherapy, as announced Nov. 14, 2017, to develop microbiome therapies to ...Estimated Reading Time: 8 mins
Seres Therapeutics - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/seres-therapeutics
- Seres Therapeutics is a microbiome therapeutics company focused on discovering and developing Ecobiotic therapeutic products. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbioticFounder: David Berry, Noubar Afeyan
Company Seres Therapeutics News, Employees and Funding ...
- https://www.topionetworks.com/companies/seres-therapeutics-5395fdcc005015045300116a
- Seres Therapeutics is a clinical stage biotherapeutic company focused on discovering and developing Ecobiotic™ therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome. Founded by Flagship VentureLabs, Seres is pioneering the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome.
Seres Therapeutics - Overview, News & Competitors ...
- https://www.zoominfo.com/c/seres-therapeutics-inc/347986776
- Seres Therapeutics to Host Second Quarter 2021 Financial Results and Operational Progress Conference Call and Webcast on August 3, 2021 CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc., (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that management will host a conference call and live audio webcast on August 3, 2021 at 8:30 a.m. ET to …Employees: 145
Have you found Seres Health Inc Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.